The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Kocsis, J. H.
* Articles by Halbreich, U.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Kocsis, J. H.
* Articles by Halbreich, U.
Related Collections
* Other Mood Disorders
* Antidepressants

Am J Psychiatry 1997; 154:390-395
Copyright © 1997 by American Psychiatric Association


BRIEF REPORTS

Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes

JH Kocsis, S Zisook, J Davidson, R Shelton, K Yonkers, DJ Hellerstein, J Rosenbaum and U Halbreich
Department of Psychiatry, New York Hospital-Cornell Medical Center, NY, USA.

OBJECTIVE: The purpose of this study was to determine the effects of antidepressant pharmacotherapy on mood symptoms and psychosocial outcomes in dysthymia. METHOD: In a multicenter, double-blind, parallel- group trial, 416 patients with a diagnosis of early-onset primary dysthymia (DSM-III-R) of at least 5 years' duration without concurrent major depression were randomly assigned to 12 weeks of acute-phase therapy with sertraline, imipramine, or placebo. The psychosocial outcome measures used in the study were the Global Assessment of Functioning Scale, the Social Adjustment Scale, the Longitudinal Interval Follow-up Evaluation psychosocial ratings, and the Quality of Life Enjoyment and Satisfaction Questionnaire. RESULTS: Sertraline and imipramine were significantly better than placebo in improving psychosocial outcomes as measured by the first three instruments. The Quality of Life Enjoyment and Satisfaction Questionnaire scores demonstrated significant improvements from baseline, and both active treatments produced significantly greater improvements than placebo. Significantly fewer patients discontinued sertraline (6.0%) than discontinued imipramine (18.4%) because of adverse events. CONCLUSIONS: Pharmacotherapy is an effective treatment for dysthymia in terms of psychosocial functioning as well as depressive symptoms, even when the dysthymia is long-standing.


This article has been cited by other articles:


Home page
AJGPHome page
D.P. Devanand, M. S. Nobler, J. Cheng, N. Turret, G. H. Pelton, S. P. Roose, and H. A. Sackeim
Randomized, Double-Blind, Placebo-Controlled Trial of Fluoxetine Treatment for Elderly Patients With Dysthymic Disorder
Am J Geriatr Psychiatry, January 1, 2005; 13(1): 59 - 68.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. H. Kocsis, A. Schatzberg, A. J. Rush, D. N. Klein, R. Howland, L. Gniwesch, S. M. Davis, and W. Harrison
Psychosocial Outcomes Following Long-term, Double-blind Treatment of Chronic Depression With Sertraline vs Placebo
Arch Gen Psychiatry, August 1, 2002; 59(8): 723 - 728.
[Abstract] [Full Text] [PDF]


Home page
J. Psychother. Pract. Res.Home page
D. J. Hellerstein, S. A. S. Little, L. W. Samstag, S. Batchelder, J. C. Muran, M. Fedak, D. Kreditor, R. N. Rosenthal, and A. Winston
Adding Group Psychotherapy to Medication Treatment in Dysthymia: A Randomized Prospective Pilot Study
J Psychother Pract Res., April 1, 2001; 10(2): 93 - 103.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
M. M. Weissman, M. Olfson, M. J. Gameroff, A. Feder, and M. Fuentes
A Comparison of Three Scales for Assessing Social Functioning in Primary Care
Am J Psychiatry, March 1, 2001; 158(3): 460 - 466.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
D. J. Hellerstein, J. H. Kocsis, D. Chapman, J. W. Stewart, and W. Harrison
Double-Blind Comparison of Sertraline, Imipramine, and Placebo in the Treatment of Dysthymia: Effects on Personality
Am J Psychiatry, September 1, 2000; 157(9): 1436 - 1444.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
A. V. Ravindran, H. Anisman, Z. Merali, Y. Charbonneau, J. Telner, R. J. Bialik, A. Wiens, J. Ellis, and J. Griffiths
Treatment of Primary Dysthymia With Group Cognitive Therapy and Pharmacotherapy: Clinical Symptoms and Functional Impairments
Am J Psychiatry, October 1, 1999; 156(10): 1608 - 1617.
[Abstract] [Full Text]


Home page
Arch Gen PsychiatryHome page
E. W. Freeman, K. Rickels, S. J. Sondheimer, and M. Polansky
Differential Response to Antidepressants in Women With Premenstrual Syndrome/Premenstrual Dysphoric Disorder: A Randomized Controlled Trial
Arch Gen Psychiatry, October 1, 1999; 56(10): 932 - 939.
[Abstract] [Full Text] [PDF]


Home page
JWatch Women's HealthHome page
Dysthymia, While Not Depression, Responds to Treatment
Journal Watch Women's Health, April 1, 1997; 1997(401): 17 - 17.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1997 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org